SCHEMBL8276010

SCHEMBL8276010

Bc1ccc([C@@H](C)NC(=O)OC(C)(C)C)cc1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 3/20 0.40
KMT2A Q03164 1/20 0.39
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ABCB1 P08183 1/20 0.38
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA7 P43166 2/20 0.37
CTSS P25774 1/20 0.37
CA4 P22748 1/20 0.37
CA9 Q16790 1/20 0.37
MAPT P10636 2/20 0.36
ATM Q13315 1/20 0.36
ACACB O00763 1/20 0.36
TRPA1 O75762 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
GABRB1 P18505 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3315171 0.87 CTSK (0.43) CTSKKMT2ATSHRHSD17B10ABCB1
SCHEMBL19595429 0.85 TRPA1 (0.42) CTSKKMT2ATSHRHSD17B10ABCB1
SCHEMBL8276846 0.84 HPGD (0.44) CTSKABCB1CA1CA2KDM4E
SCHEMBL19595090 0.84 HPGD (0.44) CTSKABCB1CA1CA2KDM4E
SCHEMBL20201946 0.83 TRPA1 (0.43) CTSKKMT2ATSHRHSD17B10ABCB1
SCHEMBL8225134 0.83 CTSK (0.40) CTSKKMT2ATSHRHSD17B10ABCB1
SCHEMBL2010271 0.83 CTSK (0.40) CTSKKMT2ATSHRHSD17B10ABCB1
SCHEMBL2010266 0.83 CTSK (0.40) CTSKKMT2ATSHRHSD17B10ABCB1
SCHEMBL29142097 0.82 HPGD (0.45) CTSKABCB1CA1CA2KDM4E
SCHEMBL16044609 0.82 CTSK (0.41) CTSKKMT2ATSHRHSD17B10ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005121130-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2005-12-22 WO disclosed